Observational analysis highlights efficacy and safety of GLP-1RAs in treating Hidradenitis Suppurativa and its comorbidities, suggesting a novel therapeutic approach.
GLP-1RAs represent a promising adjunctive or standalone treatment choice for those with HS and its related comorbidities. Further research is needed to establish their safety and efficacy in HS treatment. .
No takes yet. Share an insight, caveat, or question.
Maher et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: